LBM, fat mass, ECF/TBW and Albumin losses (r¼0.61, po0.01).
Assessing changes in muscle mass (MM) and total body water (TBW) in HD patients is notoriously difficult. Equipment is expensive and impractical for regular use by patients having home-based dialysis. Therefore the purpose was to assess the reliability of Dual Frequency Bipedal Bioelectrical Impedance Analysis (DF-BP BIA) scales in estimating TBW and MM in maintenance HD Patients. Sixty two stable HD patients from five satellite dialysis centers had BIA measurements taken before and 20 minutes after each consecutive HD session, for two to four weeks. A subset also had Bioelectrical Impedance Spectroscopy (BIS) measures taken for comparison.
Participant's intra individual percentage coefficient of variation range for MM (Pre HD ¼ 0.69 to 6.16; Post HD ¼ 0.56 to 7.68) and TBW (Pre HD ¼ 0.70 to 10.22; Post HD ¼ 0.58 to 8.78) were wide and clinically unacceptable. Bland Altman analysis of DF-BP BIA and BIS showed a bias of -2.173.2L (-8.4L to 4.2L) Pre HD; -2.972.0L (-6.8 to 1.1L) Post HD, for TBW with a strong correlation (r s ¼ 0.855 to 0.93; po0.05).
In conclusion, DF-BP BIA does not reliably estimate TBW, changes in TBW or MM in maintenance HD patients. When compared to BIS, DF-BP BIA underestimates TBW. DF-BP BIA is therefore clinically unacceptable for analysis of body composition changes in HD patients. Automated Peritoneal Dialysis (APD) has become the most popular form of peritoneal dialysis (PD) in Australia; however few studies on nutritional status in PD patients have separated APD from CAPD. Therefore the purpose was to assess the nutritional status, oral intake and self rated Quality of Life (QoL) in PD patients and compare between CAPD and APD.
10 adult CAPD and 37 APD patients on home-based peritoneal dialysis for Z 3 months had anthropometry measured, nutritional intake calculated from three day food diaries, and Patient Generated Subjective Global Assessment (PG-SGA) completed. QoL was assessed using the Medical Outcomes Study Short Form (SF-36) questionnaire.
Overall 48.9% (n¼23) were classified as well nourished, 44.7% (n¼ 21) were mild or moderately undernourished, and 6.4% (n¼3) were severely undernourished. The proportion of PD patients with energy and protein intake below evidence based guideline targets was 90.2% (n¼ 37) and 70.7% (n¼ 29), respectively. 25.5% (n¼12) of patients lost weight and 59.6% (n¼ 28) gained weight from initiation of therapy until date of assessment. Average quality of life score was 50.4718.7. QoL was correlated with PG-SGA (R2¼0.298, po0.01) with adjustment for age, gender, and length of time on PD. No significant differences were seen between CAPD and APD for PG-SGA mean numerical score, PG-SGA category, or for energy, protein, phosphate and potassium intakes. QoL was not statistically significant between modalities for any of the eight dimensions or total score.
In Conclusion, under-nutrition was highly prevalent in this small cohort of PD patients. Energy and protein intakes were below the current Australian recommendation for the majority of the sample. Nutritional status, dietary intakes and QoL outcomes did not differ between stable CAPD and APD patients. Protein-energy wasting is frequently found in haemodialysis (HD) patients. Anorexia and hypophagia contribute to malnutrition, increased morbidity and mortality, but the clinical impact of correcting hypophagia remains uncertain. We evaluated whether correction of hypophagia influences morbidity and mortality in anorexic HD patients. Thirty-four HD patients were enrolled in a 2-year follow-up programme including regular nutritional assessment. Patients not meeting nutritional requirements during the follow-up, received nutritional counselling, consisting of advice, individually tailored diet and, in case of failure of dietary intervention, artificial nutrition. Biochemical, anthropometric, body composition parameters, morbidity and mortality were recorded in all patients at 12 and 24 months.
At baseline, 14 patients (41%) were anorexic, and 20 patients (59%) nonanorexic. Anorexic patients were hypophagic and presented with reduced fatfree mass. After 12 and 24 months, cholesterol, albumin, lymphocyte count and BMI did not differ among groups, while FFM (%) in supplemented anorexic patients significantly improved, being not different any more vs nonanorexic (65.874.4 vs 65.478.9, respectively; p¼n.s.; 65.874.4 vs 66.7710.78, respectively; p¼n.s.) . Morbidity and mortality were not different among the two groups.
In conclusion, in HD patients, nutritional counselling and nutritional support positively affect nutritional status in hypophagic patients and make the risk of morbidity and mortality in anorexic patients comparable to non-anorexic. http://dx.doi.org/10. 1016/j.krcp.2012.04.487 Abstracts: The 16th International Congress on Nutrition and Metabolism in Renal Disease 2012 A57
